글로벌 방사성핵종 주입 시장 – 2029년까지의 산업 동향 및 예측

방사성핵종 주입 시장 분석 및 규모

세계보건기구에 따르면, 2012년 전 세계적으로 1,410만 건의 암이 등록되었습니다. WHO는 또한 33% 이상의 암 사례가 흡연과 담배 씹기와 관련이 있다고 밝혔습니다. 방사성핵종 주사는 양전자 방출 단층촬영(PET)을 사용하여 진단 목적으로 사용되는 방사성 화학 물질입니다 . 이 주사는 일반적으로 암과 관상동맥 질환을 진단하는 데 사용됩니다. 방사성핵종 주사는 활성 성분으로 플루오로-D-포도당을 함유하고 있으며 정맥 주사합니다. 신체에 주사되는 즉시 병리생리학적 상황에서 포도당 수치를 높입니다.

Data Bridge Market Research는 방사성핵종 주입 시장이 2022년부터 2029년까지의 예측 기간 동안 10.00%의 CAGR을 경험할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

방사성핵종 주입 시장 범위 및 세분화       

시장 정의

Radionuclide injection is radioactive substance used for diagnostic purpose with positron emission tomography (PET). Advancement in radiopharmaceutical technologies along with improved hardware and software of PET imaging are the primary factors driving the growth of radionuclide injection market.

Radionuclide Injection Market Dynamics

Drivers

• Developments in radiopharmaceutical technologies

Radionuclide injection market growth is primarily driven by developments in radiopharmaceutical technologies and better PET imaging hardware and software. Additionally, the radionuclide injection market will grow rapidly due to improved diagnostic accuracy and the low risk associated with this injection.

• Upsurge in cancer cases

The radionuclide injection market will expand greatly due to rising cancer and cardiovascular disease rates. The market for radionuclide injection will increase significantly if major industry players engage with local and regional players.

Opportunities

Radionuclides may be used in therapy, and this has been known for many years. Many benign and malignant illnesses have been effectively treated using a variety of radionuclides, including iodine-131, phosphorous-32, strontium-90, and yttrium-90. The recent development of several new radionuclides and radiopharmaceuticals for the treatment of neuroendocrine and other malignant or non-malignant tumours has accelerated the development of this area of nuclear medicine. The discipline of radionuclide therapy is currently in an exciting phase and is set to experience more expansion and advancement in the years to come.

Restraints/Challenges

Radionuclide injection is expensive, which will limit market expansion. The growth of this market would also be hampered by the scarcity of skilled professionals in developing nations.

This radionuclide injection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the radionuclide injection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Radionuclide Injection Market

People have been compelled to embrace difficult norms of social isolation and economic isolation as a result of the global COVID-19 health and economic devastation. To ensure their and their patients' safety, medical staff has been instructed to alter their daily schedules. The use of radionuclide treatment in therapeutic settings has grown. Oncology is where the majority of therapeutic radionuclide techniques are used. Due to co-morbidities and immunosuppression, cancer patients are a particularly weak and at-risk population. Another danger that needs to be taken into account while planning treatments is COVID-19. For these patients, therapeutic, preventative, and supportive measures might need to change. The most common radionuclide therapies involve patients with differentiated thyroid cancer (DTC) who need radioiodine therapy (RAI), patients with neuroendocrine tumours (NETs) who need peptide receptor radionuclide therapy (PRRT), patients with hepatocellular carcinoma (HCC) who need therapy with radiolabelled microspheres, and patients with prostate cancer and bone metastasis who need radionuclide palliative therapy.

Global Radionuclide Injection Market Scope

The radionuclide injection market is segmented on the basis of type, application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

????

• ??n??r
• ??r?n?r? ?rt?r? D??????
• ?th?r?

???l???t??n

• ?????t?l?
• ?l?n???
• D??gn??t??? ??nt?r

Radionuclide Injection Market Regional Analysis/Insights

The radionuclide injection market is analysed and market size insights and trends are provided by country, type, application as referenced above.

The countries covered in the radionuclide injection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Due to high healthcare infrastructure, North America is expected to dominate the global radionuclide injection market.

Asia-Pacific is expected to grow the market owing to increasing geriatric population and cancer incidences.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 방사성핵종 주입 시장 점유율 분석

방사성핵종 주입 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 방사성핵종 주입 시장과 관련된 회사의 초점에만 관련이 있습니다.

방사성핵종 주입 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 소피(Sofie) 주식회사 (미국)
• Qu??n'? Health System Corporation (미국)
• ?r??d???t???? Inc. (미국)
• N?? U?? LLC (미국)
• ????tr?n ?R? (미국)
• 지멘스 헬스케어 GmbH(독일)
• ?h?r??h L?b?r?t?r??? (미국)
• ?r??????n Nu?l??r LLC (미국)

SKU-68816